BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 19635031)

  • 1. Albumin microspheres for oral delivery of iron.
    Shivakumar HN; Vaka SR; Murthy SN
    J Drug Target; 2010 Jan; 18(1):36-44. PubMed ID: 19635031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced oral bioavailability of calcium using bovine serum albumin microspheres.
    Nair AB; Kaushik A; Attimarad M; Al-Dhubiab BE
    Drug Deliv; 2012 Aug; 19(6):277-85. PubMed ID: 22928732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alginate microspheres of isoniazid for oral sustained drug delivery.
    Rastogi R; Sultana Y; Aqil M; Ali A; Kumar S; Chuttani K; Mishra AK
    Int J Pharm; 2007 Apr; 334(1-2):71-7. PubMed ID: 17113732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of mannosylated liposomes for bioadhesive oral drug delivery via M cells of Peyer's patches.
    Pukanud P; Peungvicha P; Sarisuta N
    Drug Deliv; 2009 Jul; 16(5):289-94. PubMed ID: 19538011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted delivery of antigens to the gut-associated lymphoid tissues: 2. Ex vivo evaluation of lectin-labelled albumin microspheres for targeted delivery of antigens to the M-cells of the Peyer's patches.
    Akande J; Yeboah KG; Addo RT; Siddig A; Oettinger CW; D'Souza MJ
    J Microencapsul; 2010; 27(4):325-36. PubMed ID: 20055749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biodistribution of 131I-BSA loaded gelatin microspheres after peroral application to BALB/c mice--particle size study.
    Mladenovska K; Janevik EI; Glavas MD; Kumbaradzi EF; Goracinova K
    Acta Pharm; 2003 Sep; 53(3):187-97. PubMed ID: 14769242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation of chitosan microspheres by ionotropic gelation under a high voltage electrostatic field for protein delivery.
    Ma L; Liu C
    Colloids Surf B Biointerfaces; 2010 Feb; 75(2):448-53. PubMed ID: 19819676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of preparation conditions on the monodispersity of albumin microspheres.
    el-Mahdy M; Ibrahim ES; Safwat S; el-Sayed A; Ohshima H; Makino K; Muramatsu N; Kondo T
    J Microencapsul; 1998; 15(5):661-73. PubMed ID: 9743920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formulation and evaluation of ketorolac tromethamine-loaded albumin microspheres for potential intramuscular administration.
    Mathew ST; Devi SG; KV S
    AAPS PharmSciTech; 2007 Feb; 8(1):14. PubMed ID: 17408214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. pH-sensitive and mucoadhesive thiolated Eudragit-coated chitosan microspheres.
    Quan JS; Jiang HL; Kim EM; Jeong HJ; Choi YJ; Guo DD; Yoo MK; Lee HG; Cho CS
    Int J Pharm; 2008 Jul; 359(1-2):205-10. PubMed ID: 18490120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Particle uptake by Peyer's patches: a pathway for drug and vaccine delivery.
    Shakweh M; Ponchel G; Fattal E
    Expert Opin Drug Deliv; 2004 Nov; 1(1):141-63. PubMed ID: 16296726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poly(ether ester amide) microspheres for protein delivery: influence of copolymer composition on technological and biological properties.
    Ostacolo L; Russo P; De Rosa G; La Rotonda MI; Maglio G; Nese G; Spagnuolo G; Rengo S; Oliva A; Quaglia F
    Macromol Biosci; 2008 Jul; 8(7):682-9. PubMed ID: 18412287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Albumin microspheres as carriers for the antiarthritic drug celecoxib.
    Thakkar H; Sharma RK; Mishra AK; Chuttani K; Murthy RR
    AAPS PharmSciTech; 2005 Sep; 6(1):E65-73. PubMed ID: 16353965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. pH-sensitive hydrogels based on bovine serum albumin for oral drug delivery.
    Iemma F; Spizzirri UG; Puoci F; Muzzalupo R; Trombino S; Cassano R; Leta S; Picci N
    Int J Pharm; 2006 Apr; 312(1-2):151-7. PubMed ID: 16490328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biologically erodable microspheres as potential oral drug delivery systems.
    Mathiowitz E; Jacob JS; Jong YS; Carino GP; Chickering DE; Chaturvedi P; Santos CA; Vijayaraghavan K; Montgomery S; Bassett M; Morrell C
    Nature; 1997 Mar; 386(6623):410-4. PubMed ID: 9121559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of surface charge in targeting pegylated nanoparticles of sulpiride to the brain.
    Parikh T; Bommana MM; Squillante E
    Eur J Pharm Biopharm; 2010 Mar; 74(3):442-50. PubMed ID: 19941957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ondansetron-loaded chitosan microspheres for nasal antiemetic drug delivery: an alternative approach to oral and parenteral routes.
    Gungor S; Okyar A; Erturk-Toker S; Baktir G; Ozsoy Y
    Drug Dev Ind Pharm; 2010 Jul; 36(7):806-13. PubMed ID: 20136490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and characterization of sodium ferulate entrapped bovine serum albumin nanoparticles for liver targeting.
    Li FQ; Su H; Wang J; Liu JY; Zhu QG; Fei YB; Pan YH; Hu JH
    Int J Pharm; 2008 Feb; 349(1-2):274-82. PubMed ID: 17870261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biodegradable alginate microparticles developed by electrohydrodynamic spraying techniques for oral delivery of protein.
    Suksamran T; Opanasopit P; Rojanarata T; Ngawhirunpat T; Ruktanonchai U; Supaphol P
    J Microencapsul; 2009 Nov; 26(7):563-70. PubMed ID: 19839791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A one-step modified method to reduce the burst initial release from PLGA microspheres.
    Zheng C; Liang W
    Drug Deliv; 2010 Feb; 17(2):77-82. PubMed ID: 20067365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.